These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12476966)

  • 21. The hypothalamic-pituitary-adrenal and the hypothalamic- pituitary-gonadal axes interplay.
    Mastorakos G; Pavlatou MG; Mizamtsidi M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():172-81. PubMed ID: 16641855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution and pathology of frontotemporal dementia.
    Kertesz A; McMonagle P; Blair M; Davidson W; Munoz DG
    Brain; 2005 Sep; 128(Pt 9):1996-2005. PubMed ID: 16033782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
    Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease-related protein changes in purified neurons from Alzheimer's and Huntington's diseases.
    Selkoe DJ
    Trans Am Neurol Assoc; 1979; 104():70-4. PubMed ID: 162259
    [No Abstract]   [Full Text] [Related]  

  • 26. What is 'early onset dementia'?
    Miyoshi K
    Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The concept of subcortical and cortical dementia: another look.
    Whitehouse PJ
    Ann Neurol; 1986 Jan; 19(1):1-6. PubMed ID: 2868689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS.
    Beatty WW; Ryder KA; Gontkovsky ST; Scott JG; McSwan KL; Bharucha KJ
    Arch Clin Neuropsychol; 2003 Jul; 18(5):509-20. PubMed ID: 14591446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical detection of cholecystokinin and corticotrophin-releasing hormone neuropeptides in the hypothalamic paraventricular nucleus of the jerboa (Jaculus orientalis): modulation by immobilisation stress.
    Barakat Y; Pape JR; Boutahricht M; El Ouezzani S; Alaoui A; Chaigniau M; Tramu G; Magoul R
    J Neuroendocrinol; 2006 Oct; 18(10):767-75. PubMed ID: 16965295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we prevent Parkinson's and Alzheimer's disease?
    Kedar NP
    J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of maternal undernutrition on the hypothalamic-pituitary-adrenal axis responsiveness in sheep at different ages postnatal.
    Chadio SE; Kotsampasi B; Papadomichelakis G; Deligeorgis S; Kalogiannis D; Menegatos I; Zervas G
    J Endocrinol; 2007 Mar; 192(3):495-503. PubMed ID: 17332519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson-related dementias.
    Boeve BF
    Neurol Clin; 2007 Aug; 25(3):761-81, vii. PubMed ID: 17659189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.
    Pregelj P
    Psychiatr Danub; 2008 Jun; 20(2):162-7. PubMed ID: 18587285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep and quantitative EEG in neurodegenerative disorders.
    Petit D; Gagnon JF; Fantini ML; Ferini-Strambi L; Montplaisir J
    J Psychosom Res; 2004 May; 56(5):487-96. PubMed ID: 15172204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of the study of neurodegenerative disorders to the understanding of human memory.
    Panegyres PK
    QJM; 2004 Sep; 97(9):555-67. PubMed ID: 15317924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
    J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRH defects in Alzheimer's and other neurologic diseases.
    de Souza EB
    Hosp Pract (Off Ed); 1988 Sep; 23(9):59-71. PubMed ID: 2901426
    [No Abstract]   [Full Text] [Related]  

  • 39. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
    Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
    Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.
    Mozid AM; Tringali G; Forsling ML; Hendricks MS; Ajodha S; Edwards R; Navarra P; Grossman AB; Korbonits M
    Horm Metab Res; 2003 Aug; 35(8):455-9. PubMed ID: 12953161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.